Shoulder Replacement Market is predicted to reach USD 2.9 billion at a CAGR of 7.20% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Shoulder Replacement Market”.

The Shoulder Replacement market is estimated to register a CAGR of 7.20% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global Shoulder Replacement market— Johnson & Johnson, DJO, Integra LifeSciences, Smith and Nephew, Stryker, Zimmer Biomet, Arthrex, Lima, Wright Medical Group, Exactech, and B. Braun Melsungen.

Market Highlights

The global shoulder replacement market is accounted to register a CAGR of 7.20% during the forecast period. It is estimated to reach USD 2.9 billion by 2032.

The rising cases of osteoarthritis and the growing geriatric population are the main drivers of the shoulder replacement market due to the adoption of advanced technology and health awareness. Strict regulations and the high cost of shoulder arthroplasty treatments restrain the market. Additionally, the global scarcity of doctors and surgeons and the growing use of automated surgical devices are anticipated to promote the growth of the global Shoulder Replacement market.

Segment Analysis

The global shoulder replacement market has been segmented based on procedure and end user.

On the basis of the procedure, the market is segmented into total shoulder replacement, reverse shoulder replacement, partial shoulder replacement, shoulder resurfacing, and revision shoulder arthroplasty. The reverse shoulder replacement segment held the largest market share in 2022 due to the effective surgery and preservation procedure.

Based on application, the global Shoulder Replacement market has been segmented into hospitals, ambulatory surgical centres, and orthopaedic clinics. The hospital segment was expected to hold the largest market share in 2022 due to increased healthcare costs.

Access full report @ https://www.marketresearchfuture.com/reports/shoulder-replacement-market-13970

Regional Analysis

The global Shoulder Replacement market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Shoulder Replacement market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Shoulder Replacement market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Shoulder Replacement market comprises of Middle East, Africa, and Latin America.

The largest market share for Shoulder Replacement was maintained by the North American regional sector. This increase is attributed to an increase in the geriatric population. Additional market growth factors include increased investor investments, rising patient spending power, and the technology's viability. The implementation of stringent rules, the growing cases of osteoarthritis and major production companies all impact the U.S. market.

Moreover, the Europe market has been persistently growing over the forecast period. Rising implants and day-care surgeries drive the demand for Shoulder Replacement. The market expansion is also driven by government initiatives to improve healthcare infrastructure.

Additionally, due to the increasing emphasis placed on rising healthcare spending and the growing adoption of advanced products, Asia Pacific is anticipated to experience the quickest growth over the forecast period. The Asia Pacific market will benefit from a growing emphasis on health.

Furthermore, the rest of the world's Shoulder Replacement market is divided into the Middle East, Africa, and Latin America. This growth is attributed to the region's rising foreign investors to invest in automated instrument developments. Government support, a rise in investor interest, and the viability of technology in the sector are all contributing factors to the expansion of the market.

Key Findings of the Study

• The global Shoulder Replacement market is expected to reach USD 2.9 billion by 2032, at a CAGR of 7.20% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the increasing spending on healthcare and the rising adoption of advanced products.


• Based on end users, the hospital segment was attributed to holding the largest market in 2022, with an approximate market share of X–X%.


• Johnson & Johnson, DJO, Integra LifeSciences, Smith and Nephew, Stryker, Zimmer Biomet, Arthrex, Lima, Wright Medical Group, Exactech, B. Braun Melsungen.